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Effects of Hepatocyte Growth Factor on Collagen Synthesis and 
Matrix Metalloproteinase Production in Keloids
Keloids are pathologic proliferations of the dermal layer of the skin resulting from excessive 
collagen production and deposition. Hepatocyte growth factor (HGF) increases the 
expression of matrix metalloproteinase (MMP)-1 and suppresses collagen synthesis to 
modulate extracellular matrix turnover. To investigate the anti-fibrotic effects of HGF, we 
examine the mRNA expression of collagen types I and III and matrix metalloproteinase 
(MMP-1, MMP-3) on human dermal fibroblast (HDF) cell lines and keloid fibroblasts (KFs, 
n = 5) after adding various amount of HGF protein. We also evaluated the enzymatic 
activity of MMP-2, MMP-9 by zymograghy. In HDFs treated with TGF-β1 and HGF protein 
simultaneously, both type I and III collagen mRNA expression significantly decreased (P < 
0.05). Expression of MMP-1, MMP-3 mRNA also decreased. However, the mRNA 
expression of MMP-1, MMP-3 significantly increased in KFs with increasing amount of 
HGF in dose dependent manner (P < 0.05). The enzymatic activities of MMP-2 increased 
with increasing HGF protein in a dose-dependent manner. However, the enzymatic activity 
of MMP-9 did not change. These results suggest that the anti-fibrotic effects of HGF may 
have therapeutic effects on keloids by reversing pathologic fibrosis.
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INTRODUCTION
Keloids and hypertrophic scars are pathologic conditions result-
ing from excessive collagen deposition in the dermis due to skin 
injuries including surgery and trauma. They can lead to func-
tional problems such as limited joint motion and aesthetic and 
social issues for patients. At present, the demand for keloid treat-
ment is increasing. 
 Keloid fibroblasts (KFs) are similar to human normal dermal 
fibroblasts (HDFs) in size and shape, but show a great capacity 
to proliferate and produce high levels of extracellular matrix such 
as collagen, fibronectin, elastin, and proteoglycans (1-5). Keloids 
show an abnormal balance between proliferative and apoptotic 
cell death (6) and an excessive synthesis of extracellular matrix 
due to a failure to maintain homeostasis in the wound healing 
process. Many investigators have found that the excessive extra-
cellular matrix (ECM) production is related to an increase or de-
crease of matrix metalloproteinases (MMP-1, -2, -3, -9, -13) and 
an increase of tissue inhibitors of metalloproteinases (TIMPs) 
(7-10). 
 Gelatinases (MMP-2, 9) digest denatured collagens (types I 
and III) fibrils, type IV collagen, fibronectin and elastin; addi-
tionally, these enzymes can potentiate the degradation of ECM 
components by activating collagenase-3 (MMP-13) and neutro-
phil collagenase (MMP-8). Therefore, gelatinases are crucial in 
physiological processes such as tissue remodeling, and in path-
ological processes such as wound healing and the invasion of 
malignant tumors (11-13). MMP-9 activity is crucial during the 
epithelization process and early repair events, whereas the ge-
latinolytic activity of MMP-2 is important during the prolonged 
remodeling phase (14-16). The gelatinases act on cleaved colla-
gen more effectively than other MMPs (11). 
 Hepatocyte growth factor (HGF), initially discovered to be a 
potent mitogen for hepatocytes (17, 18) and also known as a “scat-
ter factor”, acts as a multifunctional mediator on many kinds of 
cells. It is secreted by mesenchymal cells and regulates cell growth, 
cell motility, apoptotic cell death (19), and the morphogenesis 
of hepatocytes, fibroblasts, and keratinocytes (20) primarily by 
activating a tyrosine kinase signaling cascade after binding to 
the proto-oncogenic c-Met receptor (21-23). It is secreted as a 
single, inactive polypeptide and is cleaved by serine proteases 
into a 69-kDa α-chain and a 34-kDa β-chain. 
 Recent studies have found a reverse anti-fibrotic effect in which 
HGF prevents fibrosis after damage to the liver (24), lungs, and 
kidneys (20, 25). HGF not only protects against fibrosis through 
inhibiting ECM deposition such as collagen but also reduces the 
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previously formed ECM by the induction of MMP-1 (26). How-
ever, these studies show these anti-fibrotic effects only in ani-
mal models and with HGF gene therapy, and the actions of HGF 
on human keloid fibroblasts have yet to be studied. 
 Some investigators have studied an anti-fibrogenic mecha-
nism of HGF in which increasing MMP expression promotes 
collagen degradation (26, 27). Adding HGF protein to fibroblast 
cultures of scleroderma patients significantly decreased colla-
gen production and increased MMP-1 expression and activity 
(26). This means that HGF may have therapeutic effect on ke-
loids that are similar to scleroderma with pathologic dermal fi-
brosis. 
 In this study, we investigated the mRNA levels of type I and 
III collagen synthesis, MMP-1, 3 expression, and MMP-2, 9 en-
zymatic activities in HDFs and KFs after administration of vari-
ous amounts of HGF protein with or without TGF-β1. 
MATERIALS AND METHODS
Keloid-derived fibroblast cultures and the human dermal 
fibroblast cell line
Keloid-derived fibroblasts (KFs, n = 5) were obtained from tissues 
excised during surgical procedures. Cells were obtained from 
the central dermal layer of active stage keloid patients (Table 1) 
after having obtained informed consent according to a protocol 
approved by the Yonsei University College of Medicine Institu-
tional Review Board. All experiments involving humans were 
performed in adherence to the Helsinki Guidelines. Keloids 
were identified by trained clinicians and pathologists. The sep-
arated cells were cultured in Dulbecco’s modified Eagle’s medi-
um (DMEM; GIBCO, Grand Island, NY, USA) supplemented 
with heat-inactivated 10% fetal bovine serum (FBS) and peni-
cillin (30 U/mL), streptomycin (300 mg/mL), and actinomysin. 
The culture medium was changed in 2-3 day intervals. All cells 
used in this study were taken before passage 5. The human nor-
mal dermal fibroblasts (HDFs) cell line was purchased from the 
American Type Culture Collection (ATCC, Manassas, VA, USA). 
The HDFs were cultured in DMEM (Gibco BRL) supplemented 
with 10% FBS (Gibco BRL), penicillin (30 IU/mL), and strepto-
mycin (300 μg/mL).
Hepatocyte growth factor (HGF) and TGF-ϐ1 treatment
The HDFs and KFs were treated with different amounts of HGF 
protein (1, 10, 20, and 40 ng). Three days after adding the HGF 
protein, the mRNA levels of collagen type I, III, MMP-1, 3 were 
examined by RT-PCR. Additionally, MMP-2 and -9 enzymatic 
activities were examined by zymography. TGF-β1 (5 ng/mL) was 
added simultaneously with the HGF protein. 
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from samples using a Trizol reagent 
(Invitrogen Corp., Carlsbad, CA, USA) according to the manu-
facturer’s protocol. One microgram of total RNA was converted 
into the complementary DNA using a First Strand cDNA Syn-
thesis kit (Promega Corp., Madison, WI, USA) with random prim-
ers. A polymerase chain reaction was performed using 2× Taq 
Premix 2 (Solgent Co., Ltd., Seoul, Korea) and the synthetic gene-
specific primers for collagen types I and III, MMP-1, MMP-3 and 
β-actin (Table 2). All target sequences were separately amplified 
for 35 cycles. Samples of each reaction product were separated 
by 2% agarose gel electrophoresis, visualized by ethidium bro-
mide staining, and photographed with 290-nm ultraviolet illu-
mination. The density of each band was measured by Image J. 
Relative expression of the mRNA of collagen types I and III, MMP-
1, and MMP-3 were normalized to the expression of an internal 
control (β-actin). 
MMP zymography
The enzyme activities of MMP-2 and MMP-9 were measured us-
ing zymography. Culture supernatants were collected and ana-
lyzed by gel substrate zymography. Briefly, 10 mL of non-reduc-
ing sample buffer (125 mM Tris-HCl [pH 6.8], 10%[v/v] glycerol, 
0.1%[w/v] BPB) was added to each sample. Samples were then 
loaded onto 12.5% SDS-PAGE gels containing 0.2% gelatin (Sig-
ma, St. Louis, MO, USA). The gels were incubated with renatur-
ing buffer (2.5% Triton X-100, 50 mM Tris-HCl, pH 7.5, and 0.1 
M NaCl) for 1 hour at room temperature, and then with devel-
oping buffer (50 mM Tris-pH (pH 7.5), 10 mM CaCl2, and 0.02% 
NaN3) for 18 hr at 37°C. The gels were then stained with 1% Coo-
Table 1. Profiles of the keloid scar fibroblasts used in the study
Case Sex Race Age (yr) Location of keloid
1 F Korean 28 Earlobe
2 F Korean 28 Shoulder
3 F Korean 27 Earlobe
4 F Korean 20 Earlobe
5 F Korean 23 Earlobe
Table 2. List of primers used in our study
Primer Sequence
Collagen I F 5´-GGTGGTGGTTATGACTTTGG-3´
R 5´-GTTCTTGGCTGGGATGTTTT-3´
Collagen III F 5´-GCTCTGCTTCATCCCACTATTA-3´
R 5´-TGCGAGTCCTCCTACTGCTAC
MMP-1 F 5´-GATGTGGAGTGCCTGATGTG-3´
R 5´-TGCTTGACCCTCAGAGACCT-3´
MMP-3 F 5´-TCATTTGGCCATCTCTTCC-3´
R 5´-CTTATCCGAAATGGCTGCAT-3´
Smad-2 F 5´-TTAAAGCACCTTGTGGAATC-3´
R 5´-AATAACGGAGAAGTGGGA-3´
Smad-3 F 5´-CGAGGGGAGGTCTTTGCG-3´
R 5´-GCTCGGGGAACCCATCTG-3´
β-actin F 5´-GTGCCACCAGACAGCACTGTGTTG-3´
R 5´-TGGAGAAGAGCTATGAGCTGCCTG-3´
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massie brilliant blue R-250, and gelatinolytic activity was detect-
ed as unstained bands on a blue background.
Statistics
Results are expressed as mean ± standard error of the mean 
(SEM). Statistical comparisons across KFs and HDF cell lines 
treated with different amounts of HGF were made using paired 
t-tests. P values less than 0.05 were considered significant.
Ethics statement
This study was approved by the institutional review board of Yon-
sei Medical Center (IRB No.: 4-2011-0072). Informed consent 
was acquired from all patients.
RESULTS
The effects of hepatocyte growth factor on the mRNA 
expression of collagen types I and III in the HDFs, TGF-ϐ1 
stimulated HDFs, and keloid fibroblasts
The mRNA expression of collagen types I and III were examined 
by RT-PCR. We found no significant differences in HDFs after 
adding HGF alone (Fig. 1A). However, when TGF-β1 (5 ng/mL) 
was added simultaneously with the HGF protein, collagen types 
I and III mRNA expression decreased. In HDFs treated with 40 
ng HGF protein, this decrease was 57% for type I and 64% for 
type III collagen (P < 0.05, Fig. 1B). On the other hand, the HGF 
protein caused no significant change in type I collagen mRNA 
expression in KFs (Fig. 1C). 
The effects of hepatocyte growth factor on the mRNA 
expression of MMP-1 and 3 in the HDFs, TGF-ϐ1 
stimulated HDFs and keloid fibroblasts
The expression of MMP-1 and MMP-3 mRNA was examined by 
RT-PCR. We found no significant differences in the expression 
of MMP-1 and MMP-3 mRNA when the HGF protein was treat-
ed alone. When TGF-β1 (5 ng/mL) was administered simulta-
neously with the HGF protein, both MMP-1 and MMP-3 mRNA 
expression decreased. This decrease was approximately 43% for 
MMP-1 and 49% for MMP-3 after adding 40 ng of HGF protein 
(Fig. 2A, B). However, mRNA expressions of MMP-1 and MMP-
3 in the KFs were increased after the administration of HGF pro-
tein alone with statistical significance (P < 0.05, Fig. 2C).
The effects of hepatocyte growth factor on MMP-2, MMP-9 
enzymatic activities
The HDFs and KFs were treated with various amounts of HGF 
protein (1, 10, 20, and 40 ng). Three days after the administration 
of HGF protein, MMP-2 and MMP-9 enzymatic activities were 
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Fig. 1. The effects of HGF protein on type I and III collagen mRNA expression in the 
human dermal fibroblast cell lines (A, B) and keloid fibroblasts (C). When TGF-β1 (5 
ng/mL) was added simultaneously with HGF protein, type I and III collagen mRNA ex-
pression significantly decrease in the HDFs (P < 0.05).
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examined by zymography. 
 For the HDFs, we found that MMP-2 enzymatic activity in-
creased after adding 1, 10, and 20 ng of HGF protein (Fig. 3A). 
However, the enzymatic activity of MMP-9 did not change. When 
TGF-β1 (5 ng/mL) was added simultaneously with HGF protein, 
the enzymatic activities of MMP-2 and MMP-9 were unchanged 
(Fig. 3B). For the KFs, we found that MMP-2 activity increased 
with increasing amounts of HGF protein in a dose-dependent 
manner (Fig. 3C). However, the enzymatic activity of MMP-9 ei-
ther did not change or showed only a slight increase. 
DISCUSSION
This study investigated the anti-fibrogenic effects of hepatocyte 
growth factor (HGF) on the human dermal fibroblasts (HDFs) 
cell line and keloid fibroblasts (KFs). Fujiwara et al. (28) found 
that the production of type 1 collagen, MMP-1, and MMP-2 was 
3- fold, 6-fold, and 2.4-fold higher, respectively, in keloid fibro-
blasts compared to normal dermal fibroblasts. In this study, KFs 
showed excessive collagen synthesis and breakdown of the ex-
tracellular matrix (ECM) due to increased MMP-1 and MMP-2 
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Fig. 2. The effects of HGF protein on MMP-1 and MMP-3 mRNA expression in the 
human dermal fibroblast cell lines (A, B) and keloid fibroblasts (C). When TGF-β1 (5 
ng/mL) was added to the HDFs simultaneously with HGF protein, MMP-1 and MMP-3 
mRNA expression decreased. However, in the KFs, MMP-1 and MMP-3 mRNA expres-
sion significantly increased with the administration of HGF (P < 0.05).
Fig. 3. Three days after adding HGF protein, the enzymatic activities of MMP-2 and 
MMP-9 were examined by zymography. For the HDFs, MMP-2 activity increased after 
adding HGF protein except 40 ng, and MMP-9 activity did not changed (A). However, 
after simultaneously adding TGF-β1, MMP-2 and MMP-9 activity were unchanged 
(B). In the KFs, (C) MMP-2 activity increased with increasing HGF protein in a dose-
dependent manner.
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activity. TGF-β1 played a role in modulating type 1 collagen, MMP-
1, and MMP-2. Since these keloids are characterized by an ac-
cumulation of collagen, it appears that the down regulation of 
collagen I and III expression and the upregulation of MMP-1 and 
MMP-2 are able to ablate the excess collagen formed by the in-
crease in synthetic activity.
 In our study, the expressions of collagen I and III mRNA induc- 
ed by exogenous TGF-β1 were suppressed by adding HGF pro-
tein on the HDFs. However, these expressions were not changed 
by adding HGF protein alone. This means that HGF does not 
influence or increase ECM production of normal dermal fibro-
blasts, and suppresses the increased expression of collagen I 
and III mRNA induced by exogenous treatment with TGF-β. This 
suggests a high potential for HGF as therapeutics in abnormal 
fibrotic disease because HGF do not affect basal collagen levels 
in normal fibroblasts.
 Applying HGF proteins to KFs did not significantly change the 
expression of collagen I and III mRNA (Fig. 1). In previous stud-
ies, collagen I and III mRNA expression was found to be more 
enhanced in KFs than HDFs, so that we expected the addition 
of HGF protein to cultured KFs to decrease collagen I and III 
mRNA expression since TGF-β is antagonized by HGF (20). How-
ever, contrary to our hypothesis, this did not happen. This seems 
to be caused by a different profibrogenic reaction with TGF-β in 
KFs compared with HDFs. More TGF-β is secreted in KFs than 
in normal fibroblasts and it plays a predominant role in the pro-
fibrogenic reaction; the profibrogenic reaction of TGF-β in KFs 
is more sensitive and persistent than in HDFs. Thus, the anti-fi-
brogenic reaction of HGF seems to be different in KFs from that 
in HDFs. Therefore, it appears that HGF protein decreases the 
expression of type I and III collagen mRNA in profibrogenic con-
ditions (HDFs adding TGF-β), but does not influence these ex-
pression in keloid-like conditions (high TGF-β concentration). 
However, Jinnin et al. (26) reported that HGF decreased the de-
position of type I collagen protein by C-met overexpression and 
MMP-1 induced collagenolysis. Therefore, further investigation 
of the effects of HGF on collagen metabolism of keloid-derived 
fibroblast would be warranted.
 Applying TGF-β (5 ng) and HGF to the cultured HDFs signifi-
cantly decreased the expression of MMP-1 and MMP-3 mRNA, 
but adding HGF alone showed no significant differences. Also, 
when TGF-β and HGF are both applied to cultured HDFs, the 
expression of collagen type I and type III mRNA decreases. Be-
cause healing of wounds such as lacerations, requires early pro-
fibrogenic conditions similar to secreted TGF-β in HDFs, HGF 
treatments may impair the wound healing process due to a de-
crease in extracellular matrix synthesis and degradation rate. In 
addition, we found no changes in MMP-9 activity in the HDFs, 
which is further evidence that HGF protein therapy will have lit-
tle benefit in the wound healing process. However, other study 
shows that continuous high HGF protein expression by the in-
troduction of the HGF gene promotes dermal regeneration, pos-
sibly not only by suppres sing the overgrowth of collagen due to 
its antifibrotic effect but also by promoting regeneration (22). 
Therefore we think that repetitive high doses of HGF could en-
hance effectively an acute wound healing. But, this approach 
has disadvantages, including the requirement for large amounts 
of HGF, the short half-life, the potential toxicity, and difficulty 
with appropriate delivery of HGF in the wound. Further studies 
are necessary for changes of collage and MMPs expression us-
ing HGF gene therapy.
 Adding HGF to cultured KFs increased MMP-1 and MMP-3 
mRNA expression (Fig. 2C). The enzymatic activity of MMP-2 
also increased with increasing HGF protein concentration (Fig. 
3). In contrast, we saw no detectable changes in MMP-9 activity 
in the KFs. The increase in MMP-2 activity is important in induc-
ing the degradation of excessive ECM in keloids, which seems to 
enhance MMP-1 and MMP-3 expression, indicating that HGF 
may have therapeutic effects on keloids by reversing pathologic 
fibrosis. The anti-fibrogenic effects of HGF generally increased 
in a dose-dependent manner, and so the appropriate treatment 
dose remains to be determined. In addition, further studies are 
necessary to develop efficient continuous release vehicles for 
HGF such as gene therapy that has its very short half-life.
 In conclusion, contrary to previously published reports which 
found that HGF promotes wound healing, this study showed 
that HGF might inhibit the profibrogenic effects in wound heal-
ing. In addition, we found that HGF may have a therapeutic ef-
fect on keloids through enhancing MMP-1 and MMP-3 mRNA 
expression and MMP-2 enzymatic activity. 
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AUTHOR SUMMARY
Effects of Hepatocyte Growth Factor on Collagen Synthesis and Matrix 
Metalloproteinase Production in Keloids
Won Jai Lee, Sang Eun Park and Dong Kyun Rah
The purpose of this study is to investigate the effects of hepatocyte growth factor (HGF) in the human dermal fibroblasts (HDFs) 
and keloid fibroblasts (KFs). In HDFs, treatment with TGF-β1 and HGF decreased type I and III collagen mRNA expression. However, 
the expressions of MMP-1, MMP-3 mRNA were also decreased. In contrast, the expressions of MMP-1 and MMP-3 mRNA were 
increased in KFs by HGF. Also, the enzymatic activity of MMP-2 was increased by HGF. These results suggest that the anti-fibrotic 
effects of HGF may have therapeutic effects on keloids by reversing pathologic fibrosis.
